Expression of Multiple Subtypes of Muscarinic Receptors and Cellular Distribution in the Human Heart
Authors:
- 1 May 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 59 (5) , 1029-1036
Abstract
Five isoforms of the muscarinic acetylcholine receptor (mAChR) have been identified by molecular cloning and designated m1–m5, of which four correspond to the functional subtypes M1, M2, M3, and M4 in primary tissues. The presence of M5receptors in tissues remains uncertain. The present study was designed to explore the diversity and cellular distribution of various mAChR subtypes in human hearts. Competition binding of [N-methyl-3H]-scopolamine methyl chloride with various mAChR antagonists yielded data consistent with the presence of multiple subtypes (M1/M2/M3/M5) of mAChRs in both human atrial (HA) and ventricular (HV) tissues. Expression of mRNAs encoding all five subtypes was readily detected by reverse transcription-polymerase chain reaction in both HA and HV samples. Immunoblotting with subtype-specific antibodies confirmed the presence of M1, M2, M3, and M5, but not M4, proteins in membrane preparations from both HA and HV. The protein levels of M1 and M2 were comparable between HA and HV. Although the density of M3appeared ∼10-fold higher in HV than HA, that of M5 was ∼5 times lower in HV than in HA. Positive immunostaining of single ventricular myocytes by M1, M2, M3, and M5 antibodies, respectively, was consistently detected. Under confocal microscopy, M5 showed characteristic localization to the intercalated discs, whereas other subtypes were more evenly distributed throughout the surface membrane. Our results provide the first molecular evidence for the presence of multiple subtypes of mAChR, including endogenous M5 receptors, in human hearts and suggest that different subtypes have different tissue distributions and cellular localization.Keywords
This publication has 41 references indexed in Scilit:
- Pseudo-Noncompetitive Antagonism of M1, M3, and M5Muscarinic Receptor-Mediated Ca2+Mobilization by Muscarinic AntagonistsBiochemical and Biophysical Research Communications, 1998
- The M5 (m5) receptor subtype: Fact or fiction?Life Sciences, 1997
- Does mammalian heart contain only the m2 muscarinic receptor subtype?Life Sciences, 1997
- Identification and Molecular Characterization of a m5 Muscarinic Receptor in A2058 Human Melanoma CellsJournal of Biological Chemistry, 1996
- Heterogeneous binding of [3H]4‐DAMP to muscarinic cholinergic sites in the rat brain: Evidence from membrane binding and autoradiographic studiesSynapse, 1991
- Vagal Stimulation of the Heartbeat: Muscarinic Receptor HypothesisJournal of Cardiovascular Electrophysiology, 1991
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- Effect of M2 muscarinic receptor antagonist 4-DAMP, on prostaglandin synthesis and mechanical function in the isolated rabbit heartGeneral Pharmacology: The Vascular System, 1989
- Characterization of muscarinic receptor subtypes in human tissuesLife Sciences, 1988
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983